Algert Global buys $4,361,958 stake in Cardinal Health Inc (CAH)

Cardinal Health Inc (CAH) : Algert Global scooped up 39,596 additional shares in Cardinal Health Inc during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 10, 2016. The investment management firm now holds a total of 57,206 shares of Cardinal Health Inc which is valued at $4,361,958.Cardinal Health Inc makes up approximately 1.69% of Algert Global’s portfolio.

Other Hedge Funds, Including , Thompson Siegel Walmsley boosted its stake in CAH in the latest quarter, The investment management firm added 193,593 additional shares and now holds a total of 484,217 shares of Cardinal Health Inc which is valued at $36,921,546. Cardinal Health Inc makes up approx 0.61% of Thompson Siegel Walmsley’s portfolio.Engineers Gate Manager Lp reduced its stake in CAH by selling 35,099 shares or 57.85% in the most recent quarter. The Hedge Fund company now holds 25,572 shares of CAH which is valued at $1,949,865. Cardinal Health Inc makes up approx 0.15% of Engineers Gate Manager Lp’s portfolio.Telos Capital Management boosted its stake in CAH in the latest quarter, The investment management firm added 11 additional shares and now holds a total of 7,418 shares of Cardinal Health Inc which is valued at $582,016. Cardinal Health Inc makes up approx 0.30% of Telos Capital Management’s portfolio.1st Source Bank boosted its stake in CAH in the latest quarter, The investment management firm added 690 additional shares and now holds a total of 44,922 shares of Cardinal Health Inc which is valued at $3,524,580. Cardinal Health Inc makes up approx 0.38% of 1st Source Bank’s portfolio.Calamos Wealth Management boosted its stake in CAH in the latest quarter, The investment management firm added 4,548 additional shares and now holds a total of 23,307 shares of Cardinal Health Inc which is valued at $1,828,667. Cardinal Health Inc makes up approx 0.40% of Calamos Wealth Management’s portfolio.

Cardinal Health Inc opened for trading at $76.34 and hit $77.46 on the upside on Monday, eventually ending the session at $77.39, with a gain of 1.50% or 1.14 points. The heightened volatility saw the trading volume jump to 17,04,111 shares. Company has a market cap of $25,215 M.

On the company’s financial health, Cardinal Health Inc reported $1.43 EPS for the quarter, beating the analyst consensus estimate by $ 0.10 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $1.33. The company had revenue of $30662.00 million for the quarter, compared to analysts expectations of $30439.59 million. The company’s revenue was up 20.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.19 EPS.

Investors should note that on May 4, 2016, Cardinal Health Inc announced a cash dividend of $0.4489. The company’s management has announced Jun 29, 2016 as the ex-dividend date and fixed the record date on Jul 1, 2016. The payable date has been fixed on Jul 15, 2016.

Many Wall Street Analysts have commented on Cardinal Health Inc. Avondale Initiated Cardinal Health Inc on Apr 19, 2016 to “Mkt Outperform”, Price Target of the shares are set at $111.Cardinal Health Inc was Initiated by Credit Suisse to “Outperform” on Mar 16, 2016. Shares were Reiterated by RBC Capital Mkts on Feb 11, 2016 to “Outperform” and Lowered the Price Target to $ 95 from a previous price target of $105 .

Cardinal Health Inc. is a healthcare services and products company. The Company operates in two segments: Pharmaceutical and Medical. The Company also provides medical products to patients in the home. In the United States the Company’s Pharmaceutical segment distributes branded and generic pharmaceutical over-the-counter healthcare and consumer products through its Pharmaceutical Distribution division to retailers hospitals and other healthcare providers. In China the Pharmaceutical segment distributes branded generic and specialty pharmaceutical over-the-counter healthcare and consumer products provides logistics marketing and other services and operates direct-to-patient specialty pharmacies through Cardinal Health China. The Medical segment distributes a range of medical surgical and laboratory products and provides services to hospitals ambulatory surgery centers clinical laboratories and other healthcare providers.

Leave a Reply

Cardinal Health Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Cardinal Health Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.